IFNB1 and myasthenia gravis: Together, these data indicate that the down-regulation of miR-29 subtypes in the thymus of MG patients could be due to a lower expression of these miRNAs in TECs, potentially mediated in response to high levels of IFN-β exposure in the MG thymus.